Results 31 to 40 of about 15,613,357 (259)

Impact of continuing care on recovery from substance use disorder.

, 2021
Continuing care is widely believed to be an important component of effective treatment for substance use disorder, particularly for those individuals with greater problem severity.
McKay, James R
core   +1 more source

A cross-sectional case-control study of familial and childhood factors associated with substance use disorder status in an Ethnic population in Northeast India

Clinical Epidemiology and Global Health
Problem considered: Substance use disorders (SUDs) are chronic conditions with psychiatric and health-related comorbidities contributing to global public health crisis.
Lalfak Zuali, Lalchhanhima Ralte, HK Laldinpuii Fente, Nachimuthu Senthil Kumar   +3 more
doaj   +1 more source

Co-occurring substance use disorder: The impact on treatment adherence in women with locally advanced cervical cancer

Gynecologic Oncology Reports, 2019
The purpose of this study was to identify the prevalence of substance use disorder and its association with adherence to treatment and survival in locally advanced cervical cancer patients treated with primary radiation therapy.
Lisa A. Rubinsak, Mishka Terplan, Caitlin E. Martin, Emma C. Fields, William P. McGuire, Sarah M. Temkin   +5 more
doaj   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk, Sebastian Michaelis, Michaela Döring, Thomas Eichholz, Ursula Holzer, Martin Ebinger, Tim Flaadt, Rupert Handgretinger, Peter Lang, Jan Frederic Weller, Markus Mezger   +10 more
wiley   +1 more source

Substance Use and Substance Use Disorders

Abstract This chapter reviews the DSM-5 definitions for substance use and other addictive disorders, their prevalence in the population, and known genetic, environmental, gene-environment, psychological, and social risk factors. It then examines how religion might influence the development and course of substance use disorders (SUDs ...
Harold G. Koenig, Tyler J. VanderWeele, John R. Peteet   +2 more
  +5 more sources

Neuropathology of substance use disorders

Acta Neuropathologica, 2013
Addictions to licit and illicit drugs are chronic relapsing brain disorders that affect circuits that regulate reward, motivation, memory, and decision-making. Drug-induced pathological changes in these brain regions are associated with characteristic enduring behaviors that continue despite adverse biopsychosocial consequences.
Cadet, Jean Lud, Bisagno, Veronica, Milroy, Christopher Mark   +2 more
openaire   +4 more sources

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source

Sex Specific Sleep Parameters Among People With Substance Use Disorder

Frontiers in Psychiatry, 2022
IntroductionSleep can have substantial impacts in substance use disorder (SUD) pathogenesis, treatment, and recovery. Sex differences exist in both sleep and SUD, but how sleep is uniquely associated with SUD by sex is not known.
Caitlin E. Martin, Caitlin E. Martin, Joseph M. Dzierzewski, Lori Keyser-Marcus, Emily K. Donovan, Tatiana Ramey, Dace S. Svikis, F. Gerard Moeller   +7 more
doaj   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye, Chimezie Okwuonu, Evelyn Idam, Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Zinnah Aloziem, Blossom Amamchukwu, Patience Elimia, Mkpoikanabasi Obot‐Obot, Henry Mbakwe, Praises Maduagwuna, Olatunji Akinrodoye, Chiamaka Anyanwu, Benjamin Anyanwu, Adedamola Akinsiku, Oluwatoyin A. Akinsiku, Muzamil O. Hassan, Fatiu A. Arogundade, Olalekan E. Ojo, Homayemem Weli, Jesupelumi Adenihun, Aderemi Adelaja, Ebun Bamgboye, Olalekan Olatise, Ade E. Faponle, Ayoola Odeyemi, Michael Muoka, Stephen Asaolu, Qudrat Busari, Blessing Dawudu, Michael Naiyeju, Rasheed A. Balogun   +33 more
wiley   +1 more source

The perspectives of people who use drugs regarding short term involuntary substance use care for severe substance use disorders

, 2021
Background: In the Canadian Province of British Columbia (BC), the BC Mental Health Act permits involuntary care for treating mental disorders. However, the Act has also been applied to provide involuntary care to individuals with a primary substance ...
Winston, Mark L., Pakhomova, Tatiana E., Thompson, Erica, MacPherson, Donald, Small, Will, Lou, Hayami, Vigo, Daniel V., Chau, Leena W., Erickson, Margaret   +8 more
core   +1 more source